You are here: Industry Insights > oncology

News List

Merck Q3 results: 5% revenue growth primarily driven by oncology pharmaceutical-technology
October 29, 2018
Revenue growth primarily driven by oncology.
Included in the Medical Insurance of China, A Comparison of Prices of Anticancer Drugs in and outside China 1℃
October 24, 2018
Maximum Price Reduction by 74%!
Glythera rebrands as Iksuda, pledging to solve ADC problems fiercebiotech
September 11, 2018
Despite their promise, antibody-drug conjugates (ADCs) have been tricky to bring to market, but the U.K. biotech formerly known as Glythera wants to change that.
Shire completes sale of oncology franchise worldpharmanews
September 03, 2018
Shire plc (LSE: SHP, NASDAQ: SHPG) announces today that it has completed the sale of its Oncology franchise to Servier S.A.S. for $2.4 billion.
Bluebird, Gritstone inks deal to develop cancer cell therapies biospectrumasia
August 24, 2018
Gritstone Oncology will receive $20M in an upfront payment and an additional $10M in the form of a Series C preferred equity investment.
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency worldpharmanews
July 19, 2018
The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor recepto
Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology worldpharmanews
July 05, 2018
Roche (SIX: RO, ROG; OTCQX: RHHBY) and Foundation Medicine, Inc. (NASDAQ: FMI) have entered into a definitive merger agreement for Roche to acquire the outstanding shares of FMI's common stock not already owned by Roche and its affiliates at a price of US
Novartis’ US Oncology head makes leap to become biotech CEO pharmafile
June 07, 2018
The departure of high-level, big pharma executives to tiny biotechs is steadily becoming a constant stream; the latest is Bill Hinshaw, former Executive Vice President of US Oncology at Novartis, who exits the company to head to Axcella Health, becoming i
Zai Lab grabs top AstraZeneca cancer executive to prep its first drug rollout fiercepharma
June 06, 2018
China’s Zai Lab is revving up for its first drug launch, and it's brought on an AstraZeneca oncology executive to lead the charge.
New drugs, new money: Surge in cancer DTC ads follows wave of I-O debuts fiercepharma
June 05, 2018
As more oncology treatments have flooded the market, so has cancer DTC advertising.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page